|
465 (PB453): RGT-264 a highly potent, selective and orally bioavailable HPK1 (MAP4K1) inhibitor augments immune activation and anti-tumor immunity |
|
|
|
Titel: |
465 (PB453): RGT-264 a highly potent, selective and orally bioavailable HPK1 (MAP4K1) inhibitor augments immune activation and anti-tumor immunity |
Auteur: |
Xiao, F. Liu, H. Wu, L. Feng, S. Liu, Y. Xiao, H. Li, H. Huang, W. Ren, X. Ren, B. Yao, L. Lin, J. Zhong, W. Xie, Z. |
Verschenen in: |
European journal of cancer |
Paginering: |
Jaargang 211 () nr. S1 pagina's p. |
Jaar: |
2024 |
Inhoud: |
|
Uitgever: |
Elsevier LTD. All rights reserved. |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|